(Q39565764)

13 September 2017

alpha 2-Antiplasmin consumption and fibrinogen breakdown during thrombolytic therapy (English)

2 references

13 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A90396

16 April 2022

α2-antiplasmin consumption and fibrinogen breakdown during thrombolytic therapy (English)

1 reference

10.1016/0049-3848(79)90118-X

Crossref

DOI

https://api.crossref.org/works/10.1016/0049-3848(79)90118-X

16 April 2022

1 reference

Collen D

1

1 reference

13 September 2017

Verstraete M

series ordinal

2

1 reference

13 September 2017

D. Collen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A90396

16 April 2022

M. Verstraete

0 references

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=90396

16 April 2022

publication date

1 January 1979

1 reference

13 September 2017

1 reference

13 September 2017

14

1 reference

13 September 2017

4-5

1 reference

13 September 2017

631-639

1 reference

10.1016/0049-3848(79)90118-X

13 September 2017

Identifiers

DOI

1 reference

release_j3jllyzvpfegnid6t7uqtrjrvi

13 September 2017

0 references

1 reference